BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 25617393)

  • 41. Evaluation of the Onclarity HPV assay on the high-throughput COR system.
    Taylor SN; Eckert K; Rucki AA; VanSickler M; Price JA; Gutierrez E; Lizzi M; Cammarata CL; Von Bredow B; Wolfe DM; Harris JM; Gregory SM; Greene WH; Vaughan LM
    Expert Rev Mol Diagn; 2021 Mar; 21(3):333-342. PubMed ID: 33849372
    [No Abstract]   [Full Text] [Related]  

  • 42. Broom versus broom-and-brush: a comparison of Surepath liquid-based Papanicolaou test (LBPT) collection devices.
    Ngae MY; Crowder CD; Kjeldahl K; Gamez R; Paulson S; McKeon DM; Goyal P; Pambuccian SE
    Cytojournal; 2009 Oct; 6():20. PubMed ID: 19876382
    [No Abstract]   [Full Text] [Related]  

  • 43. Letter to the Editor: Response.
    Morgan K; Azzani M; Khaing SL; Wong YL; Su TT
    J Low Genit Tract Dis; 2020 Oct; 24(4):424. PubMed ID: 32986389
    [No Abstract]   [Full Text] [Related]  

  • 44. Improving Laboratory Efficiency by Automation of Preanalytic Processing of ThinPrep Specimens for Real-Time PCR High-Risk HPV Testing.
    Barbieri D; Venturoli S; Costa S; Landini MP
    J Lab Autom; 2016 Jun; 21(3):432-8. PubMed ID: 25673634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.
    Monsonego J; Cox JT; Behrens C; Sandri M; Franco EL; Yap PS; Huh W
    Gynecol Oncol; 2015 Apr; 137(1):47-54. PubMed ID: 25667973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular testing opportunities on cytology effusion specimens: the pre-analytic effects of various body fluid cytology preparation methods on RNA extraction quality and targeted sequencing.
    Sura GH; Tran K; Fu C; Du L; Marczyk M; Martinez Y; Tinnirello AA; Gould RE; Lau R; Symmans WF
    J Am Soc Cytopathol; 2023; 12(1):10-19. PubMed ID: 36270909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overcoming limitations in the availability of swabs systems used for SARS-CoV-2 laboratory diagnostics.
    Nairz M; Bellmann-Weiler R; Ladstätter M; Schüllner F; Zimmermann M; Koller AM; Blunder S; Naschberger H; Klotz W; Herold M; Kerndler S; Jeske M; Haschka D; Petzer V; Schroll A; Sonnweber T; Tancevski I; Fritsche G; de Araujo MEG; Stasyk T; Huber LA; Griesmacher A; Theurl I; Weiss G
    Sci Rep; 2021 Jan; 11(1):2261. PubMed ID: 33500503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Method for preservation of DNA stability of liquid-based cytology specimens from a lung adenocarcinoma cell line.
    Matsuo Y; Yamashita K; Yoshida T; Satoh Y
    Virchows Arch; 2021 Mar; 478(3):507-516. PubMed ID: 32869115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specimen Age Stability for Human Papilloma Virus DNA Testing Using BD SurePath.
    Kubik MJ; Permenter T; Saremian J
    Lab Med; 2015; 46(1):51-4; quiz e13. PubMed ID: 25617393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes.
    Levi AW; Bernstein JI; Hui P; Duch K; Schofield K; Chhieng DC
    Arch Pathol Lab Med; 2016 Feb; 140(2):153-7. PubMed ID: 26910220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recovery of DNA from BD SurePath cytology specimens and compatibility with the Roche AMPLICOR Human Papillomavirus (HPV) Test.
    Dixon EP; Lenz KL; Doobay H; Brown CA; Malinowski DP; Fischer TJ
    J Clin Virol; 2010 May; 48(1):31-5. PubMed ID: 20233675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-risk HPV detection in specimens collected in SurePath preservative fluid: comparison of ambient and refrigerated storage.
    Hardie A; Moore C; Patnick J; Cuschieri K; Graham C; Beadling C; Ellis K; Frew V; Cubie HA
    Cytopathology; 2009 Aug; 20(4):235-41. PubMed ID: 19659956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests.
    Tardif KD; Pyne MT; Malmberg E; Lunt TC; Schlaberg R
    PLoS One; 2016; 11(2):e0149611. PubMed ID: 26905067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SurePath Specimens Versus ThinPrep Specimen Types on the COBAS 4800 Platform: High-Risk HPV Status and Cytology Correlation in an Ethnically Diverse Bronx Population.
    Naeem RC; Goldstein DY; Einstein MH; Ramos Rivera G; Schlesinger K; Khader SN; Suhrland M; Fox AS
    Lab Med; 2017 Aug; 48(3):207-213. PubMed ID: 28379422
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.